Mariner’s Repros Therapeutics Inc. RPRX Stock Holding History

Mariner’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-11,000	Closed	-$82K	–	592
2015 Q3	$82K	Buy	+11,000	New	+$84.1K	﹤0.01%	510

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

AIA

Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Mariner's RPRX Position: Q4 2015 in Review

Mariner sold out of Repros Therapeutics Inc. (RPRX) in Q4 2015, closing a stake of 11,000 shares — an estimated $82K sold.

Mariner first reported a position in RPRX in Q3 2015 and held it in 1 quarter. The position peaked at $82K in Q3 2015. 56 funds tracked by Wall St. Rank hold RPRX as of Q4 2015.

Mariner reported no remaining Repros Therapeutics Inc. position as of Q4 2015 after selling out during the quarter.
Mariner sold 11,000 Repros Therapeutics Inc. shares in Q4 2015, an estimated $82K.
Mariner first reported a position in Repros Therapeutics Inc. in Q3 2015 and held it in 1 quarter.
Mariner's Repros Therapeutics Inc. position peaked at $82K in Q3 2015.
56 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2015.

Based on Mariner's 13F filing for Q4 2015, filed 16 Feb 2016.